Next Financial Group’s Fulgent Genetics FLGT Stock Holding History

Next Financial Group’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$484K	Sell	4,808 -183	-4%	-$16.1K	0.03%	563
2021 Q3	$449K	Buy	4,991 +47	+1%	+$4.27K	0.04%	512
2021 Q2	$456K	Sell	4,944 -1,755	-26%	-$140K	0.04%	501
2021 Q1	$647K	Sell	6,699 -672	-9%	-$69.4K	0.06%	344
2020 Q4	$384K	Buy	7,371 +4,660	+172%	+$195K	0.04%	467
2020 Q3	$109K	Buy	+2,711	New	+$84.9K	0.01%	830
2020 Q2	–	Sell	-400	Closed	-$4K	–	1038
2020 Q1	$4K	Buy	+400	New	+$5.57K	﹤0.01%	1756

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Next Financial Group's FLGT Position: Q4 2021 in Review

Next Financial Group reduced its Fulgent Genetics (FLGT) stake by 3.7% in Q4 2021, selling an estimated $16.1K and leaving 4,808 shares worth $484K. The position accounts for 0.03% of the portfolio, ranked #563.

Next Financial Group first reported a position in FLGT in Q1 2020 and has held it in 7 quarters since. The position peaked at $647K in Q1 2021. 299 funds tracked by Wall St. Rank hold FLGT as of Q4 2021.

Next Financial Group held 4,808 shares of Fulgent Genetics worth $484K as of Q4 2021.
Next Financial Group sold 183 Fulgent Genetics shares in Q4 2021, an estimated $16.1K.
Fulgent Genetics made up 0.03% of Next Financial Group's portfolio in Q4 2021, its #563 holding.
Next Financial Group first reported a position in Fulgent Genetics in Q1 2020 and has held it in 7 quarters since.
Next Financial Group's Fulgent Genetics position peaked at $647K in Q1 2021.
299 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.